Edition:
United States

Endocyte Inc (ECYT.OQ)

ECYT.OQ on NASDAQ Stock Exchange Global Select Market

2.75USD
7 Dec 2016
Change (% chg)

$-0.01 (-0.36%)
Prev Close
$2.76
Open
$2.75
Day's High
$2.77
Day's Low
$2.66
Volume
37,928
Avg. Vol
39,116
52-wk High
$4.43
52-wk Low
$2.55

ECYT.OQ

Chart for ECYT.OQ

About

Endocyte Inc. (Endocyte) is a biopharmaceutical company. The Company is engaged in developing therapies for the treatment of cancer and inflammatory diseases. The Company uses its technology to create small molecule drug conjugates (SMDCs) and companion imaging diagnostics. The Company's pipeline includes Folate-Tubulysin... (more)

Overall

Beta: 1.78
Market Cap(Mil.): $116.66
Shares Outstanding(Mil.): 42.27
Dividend: --
Yield (%): --

Financials

  ECYT.OQ Industry Sector
P/E (TTM): -- 42.12 30.77
EPS (TTM): -1.01 -- --
ROI: -26.01 -0.81 15.23
ROE: -26.15 -1.52 16.56

BRIEF-Endocyte reports Q3 loss per share $0.21

* Company updated its financial expectations and now anticipates its cash balance at end of 2016 to be above $135 million

Nov 09 2016

BRIEF-Endocyte reports Q2 loss per share $0.33

* Q2 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S

Aug 04 2016

Earnings vs. Estimates